Supplementary Information
1. Transformation, cultivation and purification
Expression and purification of the norcoclaurine synthase from Thalictrum flavum variant (△29TfNCS-A79I) for reference compound synthesis (UCL London)
Expression of △29TfNCS-A79I [1] : A pJ411 plasmid containing a codon optimised Δ29TfNCS-A79I was purchased from DNA2.0 and E. coli BL21 (DE3) cells were transformed with these plasmids by a standard heat-shock protocol. The transformed cells were stored as glycerol stocks at -80 °C. An aliquot from the frozen stock was inoculated into 20 mL of TB medium (containing 50 μg/mL kanamycin). Starter cultures were incubated overnight at 37 °C, shaking at 250 rpm. A 4 mL sample of the overnight starter culture was added to 100 mL of TB medium.
The expression cultures were incubated for 2 hours at 37 °C, followed by 1 hour at 25 °C, whilst shaking at 250 rpm. Expression was induced by the addition of 100 μL of 500 mM IPTG.
Cultures were incubated for a further 3 hours at 25 °C prior to harvesting, whilst shaking at 250 rpm. Cells were harvested by centrifugation at 10,000 g for 10 mins at 4 °C. Supernatant was removed and the cells stored at -20°C until purification.
Purification of △29TfNCS-A79I (10 mL scale): Cell pellets were thawed and suspended in BugBuster (10 mL), a detergent based lysis agent for E. coli (Novagen). The insoluble portion of the lysate was pelleted by centrifugation at 10,000 x g for 30 minutes at 4 °C. The supernatant was removed and filtered through a glass fibre prefilter and 0.2 μm cellulose acetate syringe filter. An empty and clean PD-10 column (GE) was charged with Ni-NTA (2 mL).
The column was washed with distilled water (10 mL), followed by binding buffer (0.1 M HEPES, 20 mM imidazole, 100 mM NaCl, pH 7.5; 10 mL). The filtered supernatant was passed through the Ni-NTA column, and the column was then washed with binding buffer (10 mL) followed by wash buffer (0.1 M HEPES, 40 mM imidazole, 100 mM NaCl, pH 7.5; 20 mL). The bound protein was then eluted with elution buffer (0.1 M HEPES, 500 mM imidazole, 100 mM NaCl, pH 7.5; 5 mL). The eluent containing pure enzyme was buffer exchanged into 0.1 M HEPES pH 7.5, using a PD-10 column. Glycerol was added (10% v/v) and the concentration of the protein determined by absorbance at 280 nm. The protein was divided into 0.5 mL samples and frozen in liquid nitrogen. The purified protein was stored at -80 °C. [2] Figure 1 SDS-PAGE of △29TfNCS-A79I. 1: protein ladder; 2: flow through with wash buffer (containing 20 mM imidazole); 3: flow through with wash buffer (containing 40 mM imidazole); 4-10: purified protein in different fractions.
According to SDS-gel estimation the protein purity was >98% as no further bands were obvious. The concentration of prepared △29TfNCS-A79I was measured using Nanodrop 
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Acetohydroxy acid synthase I from Escherichia coli (EcAHAS-I)
Cells containing a plasmid encoding for EcAHAS-I as described in SI-1.3.1 were produced in a 1 L-DASGIP cultivation system in 0.645 L autoinduction medium and 0.450 L feed solution at 20 °C, 1200 rpm, pH 7, 6 -18 sL/h oxygen supply (30% dissolved oxygen concentration) and 1 mL/L anti foam 204. The 33% feed solution was added steadily (6.75 mL/h, table 1). Hielscher, S14 D-sonotrode, cycle 0.5, amplitude 70%) and cell debris removed by centrifugation (JA-20, 19000 rpm, 4 °C, 35 min). EcAHAS-I was purified from crude cell extract (column material: Ni-NTA superflow, Qiagen) with an automated Äkta purifier system (GE Healthcare). Afterwards the proteins were desalted and rebuffered by size exclusion chromatography (Sephadex G25 column) and the purification success tested by SDS-PAGE.
EcAHAS-I consists of a catalytic subunit (62.5 kDa) and a regulatory subunit (11.1 kDa), which both need to be present in order to maintain maximal enzyme activity. [3] [4] [5] Enzymes were lyophilised (Christ, LT105) and stored at -20 °C (330 mg lyophilisate, 0.4 mg protein/mg lyophilisate (Bradford)). According to SDS-gel estimation the protein purity was >95%.
Transaminase from Chromobacterium violaceum (Cv2025)
Cells containing a plasmid encoding for transaminase Cv2025 were cultivated as described elsewhere. [6] [7] [8] Cv2025 was purified by Ni-NTA purification from crude cell extract (column material: Ni-NTA superflow, Qiagen, automated Äkta purifier system, GE Healthcare) and desalted and rebuffered by size exclusion chromatography (Sephadex G25 column). The enzymes were lyophilised (Christ, LT105, ~1 mg protein/mg lyophilisate, Bradford, purity 90%, protein content 70% according to SDS-PAGE) and stored at -20 °C. [9] According to SDS-gel estimation the protein purity was >98% as no further bands were obvious. TCCTGGAACAGCAGGGCATTAAGATTGTGACAGGCATTCCGGGCGGTTCTATCCTGCCTGTTTACGA  TGCCTTAAGCCAAAGCACGCAAATCCGCCATATTCTGGCCCGTCATGAACAGGGCGCGGGCTTTATC  GCTCAGGGAATGGCGCGCACCGACGGTAAACCGGCGGTCTGTATGGCCTGTAGCGGACCGGGTGC  GACTAACCTGGTGACCGCCATTGCCGATGCGCGGCTGGACTCCATCCCGCTGATTTGCATCACTGGTC  AGGTTCCCGCCTCGATGATCGGCACCGACGCCTTCCAGGAAGTGGACACCTACGGCATCTCTATCCC  CATCACCAAACACAACTATCTGGTCAGACATATCGAAGAACTCCCGCAGGTCATGAGCGATGCCTTCC  GCATTGCGCAATCAGGCCGCCCAGGCCCGGTGTGGATAGACATTCCTAAGGATGTGCAAACGGCAG  TTTTTGAGATTGAAACACAGCCCGCTATGGCAGAAAAAGCCGCCGCCCCCGCCTTTAGCGAAGAAAG  CATTCGTGACGCAGCGGCGATGATTAACGCTGCCAAACGCCCGGTGCTTTATCTGGGCGGCGGTGTG  ATCAATGCGCCCGCACGGGTGCGTGAACTGGCGGAGAAAGCGCAACTGCCTACCACCATGACTTTA  ATGGCGCTGGGCATGTTGCCAAAAGCGCATCCGTTGTCGCTGGGTATGCTGGGGATGCACGGCGTG  CGCAGCACCAACTATATTTTGCAGGAGGCGGATTTGTTGATAGTGCTCGGTGCGCGTTTTGATGACC  GGGCGATTGGCAAAACCGAGCAGTTCTGTCCGAATGCCAAAATCATTCATGTCGATATCGACCGTGC  AGAGCTGGGTAAAATCAAGCAGCCGCACGTGGCGATTCAGGCGGATGTTGATGACGTGCTGGCGCA  GTTGATCCCGCTGGTGGAAGCGCAACCGCGTGCAGAGTGGCACCAGTTGGTAGCGGATTTGCAGCG  TGAGTTTCCGTGTCCAATCCCGAAAGCGTGCGATCCGTTAAGCCATTACGGCCTGATCAACGCCGTTG  CCGCCTGTGTCGATGACAATGCAATTATCACCACCGACGTTGGTCAGCATCAGATGTGGACCGCGCA  AGCTTATCCGCTCAATCGCCCACGCCAGTGGCTGACCTCCGGTGGGCTGGGCACGATGGGTTTTGGC  CTGCCTGCGGCGATTGGCGCTGCGCTGGCGAACCCGGATCGCAAAGTGTTGTGTTTCTCCGGCGACG  GCAGCCTGATGATGAATATTCAGGAGATGGCGACCGCCAGTGAAAATCAGCTGGATGTCAAAATCA  TTCTGATGAACAACGAAGCGCTGGGGCTGGTGCATCAGCAACAGAGTCTGTTCTACGAGCAAGGCG  TTTTTGCCGCCACCTATCCGGGCAAAATCAACTTTATGCAGATTGCCGCCGGATTCGGCCTCGAAACC  TGTGATTTGAATAACGAAGCCGATCCGCAGGCTTCATTGCAGGAAATCATCAATCGCCCTGGCCCGG  CGCTGATCCATGTGCGCATTGATGCCGAAGAAAAAGTTTACCCGATGGTGCCGCCAGGTGCGGCGA  ATACTGAAATGGTGGGGGAATAAGCCATGCAAAACACAACTCATGACAACGTAATTCTGGAGCTCAC  CGTTCGCAACCATCCGGGCGTAATGACCCACGTTTGTGGCCTTTTTGCCCGCCGCGCTTTTAACGTTG  AAGGCATTCTTTGTCTGCCGATTCAGGACAGCGACAAAAGCCATATCTGGCTACTGGTCAATGACGA 
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Reaction conditions 2.1 Enzymatic 3-step cascade reaction
Step 1: Carboligation of 3-hydroxybenzaldehyde and sodium pyruvate towards (R)-1-
hydroxy-1-(3-hydroxyphenyl)propan-2-one
The HEPES-buffer pH 7.5 (100 mM, 238.3 g/mol, Biochrom) was containing 5 mM Ltd: Microcon-10, centrifugal filters).
Step 2 
Chemoenzymatic 3-step cascade reaction
Step 1 and 2 occurred as described above.
Step Table 6 Retention times of the carboligation step compounds measured by HPLC IE-column gradient method (Table 5) . 
Sample preparation of transamination measurements -SFC
For optical purity measurements of metaraminol, SFC analytics were used (Agilent SFC1260 Infinity, DAD). Two columns were connected in a row to increase the separation efficiency (IAcolumn (Chiralpak) and AD-H-column (Chiralpak), each 5 µm, 4.6 mm x 250 mm. The mobile phase was a mixture of 88% supercritical CO2 and 12% MeOH + 0.5% DEA, flow: 0.8 mL/min, 210 nm, 5 µL injection volume, 30 °C. 
Figure 7
Chromatogram (HPLC) of the transamination reaction from 3HPAC and IPA towards metaraminol after 8 h, zoomed in. Table 9 Retention times of transamination step compounds measured by SFC (SP: unidentified product). The products were identified by comparison with the reference compound ( Fig. 9 ) and detection by GC-TOF-MS (see Fig. 10-15 ). Conversions were calculated by substrate depletion of 2-amino-1-(3-hydroxyphenyl)propan-1-ol. 
Substance (S)-3HPAC SP (R)-3HPAC (1S,2S)/(1S,2R)-
2-amino-1-(3- hydroxyphenyl) propan-1-ol (1R,2R)-2- amino-1-(3- hydroxyphenyl) propan-1-ol (1R,2S)- metaraminol
Substance (S)-isoquinoline (R)-isoquinoline 2-amino-1-(3-hydroxyphenyl)-propan-1-ol 3H-benzylamine
Retention times (RT)
5.6 min 9.2 min 15.6 min 23.8 min
Product identification by GC-TOF-MS
Sample preparation (lyophilisation and derivatisation) and GC-TOF-MS measurements were kindly provided by Jochem Gätgens, Bioprocess & Bioanalytics group, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, according to a protocol described elsewhere. [11] 2-amino-1-(3-hydroxyphenyl)
propan 
Peak identification
For the identification of known metabolites we used a baseline noise subtracted fragment pattern in comparison to our inhouse database JuPoD, the commercial database NIST11
(National Institute of Standards and Technology, USA) and the free available database GMD (MPI of Molecular Plant Physiology, Golm, Germany). [11] , [12] Unknown peaks were identified by structural combination of elemental compositions and verified by virtual derivatisation and fragmentation of the predicted structures.
GC-TOF-MS data of the 3-step cascade reaction.
Figure 10 GC-TOF-MS data of the carboligation step (1-hydroxy-1-(3-hydroxyphenyl)propan-2-one is identified as main product of this step, glycerol is found in the reaction mixture, due to the use of not purged syringe filters).
Figure 11
GC-TOF-MS data of the transamination step, 2-amino-1-(3-hydroxyphenyl)propan-1-ol is identified as main product of this step, glycerol is found in the reaction mixture, due to the use of not purged syringe filters.
Figure 12
GC-TOF-MS data of the Pictet-Spengler condensation step (1-benzyl-3-methyl-1,2,3,4-tetrahydroisoquinoline-4,6-diol is identified as main product of this step, glycerol is found in the reaction mixture due to the use of not purged syringe filters). 
Scheme 4
An NOE was observed between 1-H and 3-H, which established that the stereochemistry at C-1 was the (S)-configuration (note reversal of stereocenter methyl-and hydroxy groups compared to the previous compound). The reaction mixture was then extracted with ethyl acetate (3 × 10 mL). The organic phases were combined and washed with brine (10 mL), dried over anhydrous Na2SO4, filtered and concentrated under vacuum to obtain the crude product. Both the reaction mixture above and the crude product were analysed by 1 H NMR spectroscopy and NMR NOESY experiments. This data confirms that under the KPi reaction conditions for the final step, the major-(1S,3S,4R)-isomer is formed with some (1R,3S,4R)-isomer (termed here major-R) in a ratio of 96:4 by chiral HPLC. In addition a small amount of the ortho-product (termed here minor-S or R) was produced <4%. 
(1S,3S
Conversion of 2-amino-1-(3-hydroxyphenyl)propan-1-ol isomers by norcoclaurine synthase variants and phosphate (step 3)
The following NCS were screened against all four isomers of 2-amino-1-(3- A substrate screen for most suitable substrates in terms of good conversion and highest stereoselectivity for the phosphate catalysed Pictet-Spengler reaction was performed.
Product peaks were tentatively assigned, as chemical standards were not available at the time. 
